Status:
WITHDRAWN
A Novel Augmented Reality System (ARssist) for the Assistant Surgeon in Robotic Assisted Surgery
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Robotic prostatectomy is a surgery for treating localized prostate cancer. The ARssist system is a novel augmented reality system designed for the assistant surgeon, allowing delivery of augmented rea...
Detailed Description
The da Vinci robotic surgery system offers advantages such as immersive three-dimensional visualization, intuitive control, and high degree of movement freedom to the chief surgeon. However, major sur...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old with informed consent
- Suitable for minimally invasive surgery
- Clinically diagnosed with urological conditions that are indicated for robotic assisted radical prostatectomy with or without lymph node dissection
Exclusion
- Body mass index ≥ 35 kg/m2
- Contraindication to general anaesthesia
- Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
- Untreated active infection
- Uncorrectable coagulopathy
- Presence of another malignancy or distant metastasis
- Emergency surgery
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04304079
Start Date
January 1 2022
End Date
May 31 2024
Last Update
January 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince of Wales Hospital
Hong Kong, Hong Kong